Precautions

Activation of Habit / Hypomanie: During the premarketing of studies implicating principally depressed patients, hypohabit or habit produced in about 1 % of patients dealt with fluvoxamine. The activation of habit / hypomanie was also announced in patients' small proportion with the riot emotional importing which was treated with other commercialised antidepressants. As with all antidepressants, fluvoxamine maleate should be used carefully in the patients with a history of habit.

Seizures: During the premarketing of studies, seizures were announced in 0.2 % of fluvoxamine-treated patients. Fluvoxamine maleate should be used carefully in the patients with a history of seizures. He should be stopped in any patient who develops seizures.

Suicide: the possibility of a suicide attempt is inherent in the patients with the depressive symptoms, if these occur in primary depression or in association with another primary riot such as OCD. The surveillance close to high patients of risk should accompany the initial therapy of medicament. Prescripts for fluvoxamine maleate should be written for the smallest quantity of tablets in harmony with good patient direction to reduce the risk of overdose.

Use in the Patients with the Illness of Element: clinical experience nearly controlled with fluvoxamine maleate in the patients with the element systematic illness is limited. Caution is recommended in fact to manage fluvoxamine maleate to the patients who diseases or conditions which could affect answers hemodynamic or a metabolism.

Interference with Cognitive or motorised Performance: As any medicament psychoactive can diminish judgement, reflexion, or motorised knowledge, they should inform patients of the dangerous machines of working, by including cars, until they are sure that fluvoxamine maleate therapy does not affect unfavourably their capacity to devote itself to such activities.